JBM is an evidence-based medical marketing consultancy founded as JB Medical in 1997,
and based in the UK.
We employ research and health economics to successfully market your product and disease areathrough appropriate communication channels.
The breadth of our professional skills and services provide continuous support throughout the product life-cycle. Direct and personal contact with medical professionals ensures you will benefit from a marketing perspective that is unique within the consultancy sector.
First-hand medical and commercial experience has shown that an integrated marketing strategy employing research, health economics and medical communication will drive behavioural change. Central to our philosophy is the belief that effective communication of a robust evidence-based message changes clinical practice.
The tension resulting from ever-increasing demands upon healthcare systems to provide access to innovative medicines with finite resources has established a mandate for evidence-based marketing.
Appropriate research and health economic analysis must be clearly communicated to key prescribing and commissioning decision makers to ensure identification of resources to drive change in clinical practice and so achieve marketing success.
JBM's approach to customer service is founded on the principles of understanding, commitment and trust.
Our experience of supporting product teams throughout the life-cycle means that we can empathise and provide insight to address the challenges faced at every stage of product marketing.
JBM Research offers bespoke research tailored to your product's needs, creating a platform for growth into new or established markets.
JBM Health Economics produces robust health economic analyses to provide rigorous validation of your product proposition. Our health technology appraisals offer assurance that your product will be appropriately positioned in national guidelines.
JBM Communications ensures your marketing messages are delivered in a credible, controlled and effective manner, through burden of disease modelling, formulary inclusion materials, presentations and training, publication planning, advisory boards and our referencing service.